Global Medical Exoskeleton Market is Set to Witness High Growth
Global Medical Exoskeleton Market is Set to Witness High Growth
The Global Medical Exoskeleton Market Demand is estimated to be valued at US$ 411.73 Bn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period of 2024 to 2031.

The global medical exoskeleton market includes robotic exoskeleton suits that help support body limbs or provide mobility for people with motor disabilities or weaknesses. Medical exoskeletons are wearable robotic suits that aid in rehabilitation and reduce pain for people who have lower or higher limb disabilities, muscular dystrophies, multiple sclerosis, strokes, spinal cord injuries and other conditions. They also help surgeons with increased control and reduced fatigue in long surgeries. The medical exoskeleton market has seen rapid technological advancements, making them more lightweight, portable and affordable. With a growing geriatric population and increasing number of people struggling with mobility issues and motor disabilities, the need for medical exoskeletons has risen greatly.

Key Takeaways

Key players operating in the global medical exoskeleton market are Energizer Holding, Inc., PowerbyProxi, Pathronic AG, Qualcomm Technologies, Inc., ConvenientPower HK Limited, Powermat Technologies, WiTricity Corporation, Xiaomi Inc., Integrated Device Technology Inc., Leggett and Platt Inc., and Texas Instruments Inc. Key players are focusing on innovations to develop more lightweight and portable medical exoskeletons using cutting-edge technologies such as servo motors, lithium-ion batteries, and 3D printing. This is expected to boost market adoption rates.

The growing Global Medical Exoskeleton Market Demand for improved mobility for the disabled and elderly populations around the world presents a major business opportunity for medical exoskeleton providers. With rapid technological advancements, exoskeletons are becoming more affordable and accessible. Companies are developing innovative business models to lease exoskeleton equipment and provide subscription services in more countries. This is allowing patients to trial and purchase exoskeletons without large upfront costs.


Key players are also expanding their global footprint by establishing manufacturing and distribution facilities in strategic markets. Many players have expanded to Asia Pacific and Europe in recent years due to favorable regulations and growing demand from aging populations. Partnerships with local healthcare providers and distributors have also helped gain higher market access. Further expansion focus on countries with improving healthcare infrastructure and supportive insurance/funding for such devices.

Market Drivers:
Rising geriatric population worldwide: The growing elderly population is more prone to mobility issues, strokes and disabilities which fuels the need for medical exoskeletons to support independent living. By 2050, over 16% of the world population will be over the age of 65.

Technological advancements: Exoskeleton technology is rapidly evolving, with innovative companies developing lighter, wearable and low-cost robotic suits using novel materials, electric actuators and embedded sensors for improved usability and precision. Ongoing R&D is expected to deliver improved patient outcomes.

Market Restraints:
High equipment costs: Despite technological developments, medical-grade exoskeletons still represent a significant capital investment, limiting widespread adoption. Substantial reimbursement challenges also remain a barrier for many healthcare systems and patients.

Limited clinical evidence: While results are promising, long term clinical evidence on patient outcomes, safety, cost-effectiveness and social impact remains limited for many exoskeleton systems. Ongoing research studies may help address such concerns and unlock greater market potential.

Segment Analysis
The medical exoskeleton market is segmented based on product type, mobility, extremity, application and region. The product type segment includes full body exoskeletons and partial body exoskeletons. Partial body exoskeletons dominates the segment as they can provide mobility assistance to patients who have lost limb functionality or suffered from paralysis. Key applications of partial body exoskeletons include stroke recovery and rehabilitation, spinal cord injury recovery and repair, and physical training for elderly people with mobility issues.

The extremity segment is divided into lower extremity medical exoskeletons and upper extremity medical exoskeletons. The lower extremity medical exoskeletons segment has the highest market share currently as lower body mobility issues are more commonly faced. These exoskeletons help patients with lower body mobility impairments regain walking ability or enhance existing mobility. The application segment consists of rehabilitation, mobility aid, and others. Rehabilitation dominates due to the increasing spinal cord injuries, strokes and elderly population.

Global Analysis
Regionally, North America leads the global medical exoskeleton market currently owing to significant investments in healthcare research and rising acceptance of novel medical technologies. Asia Pacific is projected to grow at the fastest rate during the forecast period due to increasing investment in healthcare technologies by regional governments and expanding medical tourism industry. Key factors fueling growth in the Asia Pacific region include growing geriatric population, rising incidence of road accidents and neurological disorders, and increasing healthcare spending.

Get more insights on Medical Exoskeleton Market

Also read related article on Myopia Control Lenses Market

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations